Grindeks Group provides global partners with out-licensing solutions for finished dosage forms, including tablets, capsules, injections and semi-solids.
We offer ready-to-file dossiers and marketing authorization packages suitable for EU and international markets. Our R&D pipeline includes generic and fixed-dose combination products covering major therapeutic areas such as cardiology, neurology, oncology, diabetes, dermatology, and pain management.
For collaboration inquiries:
Please reach our Business Development team at [email protected].
